{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuropathic+Pain", "query": { "condition": "Diabetic Neuropathic Pain" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 88, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuropathic+Pain&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T04:50:54.152Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01579279", "title": "A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathic Pain" ], "interventions": [ { "name": "ABT-652 6 mg", "type": "DRUG" }, { "name": "ABT-652 12 mg", "type": "DRUG" }, { "name": "ABT-652 12 mg - 18 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1, "start_date": "2012-04", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2013-09-26", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 8, "location_summary": "Anaheim, California • Walnut Creek, California • Milford, Connecticut + 5 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01579279" }, { "nct_id": "NCT01314222", "title": "Diabetic Peripheral Neuropathic Pain (DPNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathic Pain" ], "interventions": [ { "name": "BMS-954561", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo matching BMS-954561", "type": "DRUG" }, { "name": "Placebo matching Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 178, "start_date": "2011-03", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2015-12-07", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 21, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Lomita, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Lomita", "state": "California" }, { "city": "Los Gatos", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01314222" }, { "nct_id": "NCT04707157", "title": "Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathic Pain" ], "interventions": [ { "name": "LY3556050", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2021-05-06", "completion_date": "2022-06-13", "has_results": true, "last_update_posted_date": "2023-11-02", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 35, "location_summary": "Chandler, Arizona • Glendale, Arizona • Tempe, Arizona + 28 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04707157" }, { "nct_id": "NCT02328911", "title": "Laser Therapy for Diabetic Peripheral Neuropathic Pain", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "Laser treatment", "type": "DEVICE" }, { "name": "Sham treatment", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2015-01", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-09-28", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02328911" }, { "nct_id": "NCT00829387", "title": "Cognitive Behavioral Therapy for Diabetic Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Peripheral Neuropathic Pain" ], "interventions": [ { "name": "CBT plus standard pharmaceutical care (CBT/SC)", "type": "BEHAVIORAL" }, { "name": "Diabetic Education plus standard pharmaceutical care (ED/SC)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Connecticut Healthcare System", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2010-03", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2015-06-18", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 2, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" }, { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00829387" }, { "nct_id": "NCT07250828", "title": "Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Painful Diabetic Neuropathy (PDN)", "Diabetic Neuropathy", "Neuropathic Pain", "Chronic Pain" ], "interventions": [ { "name": "BurstDR Spinal Cord Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "TriCity Research Center", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 20, "start_date": "2025-12-15", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 1, "location_summary": "Grand Island, Nebraska", "locations": [ { "city": "Grand Island", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07250828" }, { "nct_id": "NCT00904202", "title": "A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postherpetic Neuralgia", "Diabetic Neuropathy", "Complex Regional Pain Syndrome", "Carpal Tunnel Syndrome", "HIV Neuropathy", "Idiopathic Sensory Neuropathy", "Peripheral Neuropathy" ], "interventions": [ { "name": "Placebo Capsules + Placebo Patch", "type": "DRUG" }, { "name": "Placebo capsules + Lidoderm®", "type": "DRUG" }, { "name": "Gabapentin + Placebo", "type": "DRUG" }, { "name": "Gabapentin + Lidoderm®", "type": "DRUG" }, { "name": "Gabapentin 300 mg capsules 1800 mg/day + placebo patch", "type": "DRUG" }, { "name": "Gabapentin 1800 mg/day + Lidoderm patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endo Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2003-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2024-01-02", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 7, "location_summary": "Birmingham, Alabama • Hueytown, Alabama • Phoenix, Arizona + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00904202" }, { "nct_id": "NCT00643760", "title": "A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuropathy, Diabetic" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "GEn 1200mg/day", "type": "DRUG" }, { "name": "GEn 2400mg/day", "type": "DRUG" }, { "name": "GEn 3600mg/day", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-07-22", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 90, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Dothan, Alabama + 81 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643760" }, { "nct_id": "NCT04454424", "title": "Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Endometriosis Related Pain", "Overactive Bladder", "Diabetic Neuropathic Pain", "Refractory or Unexplained Chronic Cough" ], "interventions": [ { "name": "BAY1817080", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 37, "start_date": "2020-07-23", "completion_date": "2021-12-15", "has_results": false, "last_update_posted_date": "2023-01-20", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 2, "location_summary": "Miami, Florida • Orlando, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04454424" }, { "nct_id": "NCT06568042", "title": "Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuropathic Pain", "Distal Sensory Polyneuropathy" ], "interventions": [ { "name": "LY3848575", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 558, "start_date": "2024-08-22", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-05-22T04:50:54.152Z", "location_count": 24, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Fresno, California + 20 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568042" } ] }